Clinical trial

The Possible Effects of Roflumilast on Obesity Related Disorders

NCT04800172

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2021-05-01

PhasePHASE3

Study timeline

Study start (actual)2021-05-01Date precision: day

Registry last updated2022-04-05

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Obesityunresolved

PreDiabetesunresolved

Interventions

RoflumilastDRUG · verified · RxNorm: roflumilast

placeboDRUG

Sponsors & collaborators

Tanta Universitylead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04800172 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.